Literature DB >> 9776123

Factor XIII insufficiency in a patient with severe psoriasis vulgaris, arthritis, and infirmity.

K Heinle1, O Adam, G Rauh.   

Abstract

Factor XIII (FXIII) links soluble fibrin monomers and collagen fibres to stable fibrin connections. Deficiency of FXIII, caused by dyspoiesis or increased consumption, results in a bleeding tendency and wound healing complications. Although the decrease of FXIII and successful replacement in patients with wound healing complications after surgery have been described by several authors, it is rarely considered that patients with autoimmune diseases, bleeding or healing complications may suffer from FXIII deficiency. We report a patient with severe psoriasis vulgaris generalisata with large, painful erythemas, bleeding tendency, joint contractions and infirmity, whose FXIII activity was 19%. After successful replacement the bleeding tendency vanished, and a marked improvement of skin and joint mobility allowed mobilisation and administration of physical therapy, whereby some independence and mobility were restored to the patient.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9776123     DOI: 10.1007/bf01451020

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  11 in total

1.  FUNCTIONAL EVALUATION: THE BARTHEL INDEX.

Authors:  F I MAHONEY; D W BARTHEL
Journal:  Md State Med J       Date:  1965-02

2.  The influence of fibrin stabilizing factor on the growth of fibroblasts in vitro and wound healing.

Authors:  E BECK; F DUCKERT; M ERNST
Journal:  Thromb Diath Haemorrh       Date:  1961-12-15

3.  Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin.

Authors:  R Cerio; C E Griffiths; K D Cooper; B J Nickoloff; J T Headington
Journal:  Br J Dermatol       Date:  1989-10       Impact factor: 9.302

4.  [Factor XIII concentration and wound healing].

Authors:  F W Gierhake; W Volkmann; W Becker; H Schwarz; H G Schwick
Journal:  Dtsch Med Wochenschr       Date:  1970-07-10       Impact factor: 0.628

5.  Treatment of Crohn's disease fistulas with coagulation factor XIII.

Authors:  N Oshitani; S Nakamura; T Matsumoto; K Kobayashi; A Kitano
Journal:  Lancet       Date:  1996-01-13       Impact factor: 79.321

6.  Factor XIII substitution in ulcerative colitis.

Authors:  R Lorenz; P Born; P Olbert; M Classen
Journal:  Lancet       Date:  1995-02-18       Impact factor: 79.321

7.  Proliferating cells in psoriatic dermis are comprised primarily of T cells, endothelial cells, and factor XIIIa+ perivascular dendritic cells.

Authors:  G S Morganroth; L S Chan; G D Weinstein; J J Voorhees; K D Cooper
Journal:  J Invest Dermatol       Date:  1991-03       Impact factor: 8.551

8.  The role of factor XIIIa-positive dermal dendrocytes in HIV-1-positive psoriatics.

Authors:  F van Neer; V Zemelman; R Cerio; J Langtry; R C Staughton
Journal:  Br J Dermatol       Date:  1993-01       Impact factor: 9.302

9.  [Factor XIII in the treatment of postoperative refractory wound-healing disorders. Results of a controlled study].

Authors:  Y Mishima; F Nagao; K Ishibiki; M Matsuda; N Nakamura
Journal:  Chirurg       Date:  1984-12       Impact factor: 0.955

10.  [Substitution of factor XIII concentrate in treatment refractory ulcerative colitis. A prospective pilot study].

Authors:  R Lorenz; P Born; M Classen
Journal:  Med Klin (Munich)       Date:  1994-10-15
View more
  1 in total

1.  Plasma factor XIII activity in patients with disseminated intravascular coagulation.

Authors:  Jae Woo Song; Jong Rak Choi; Kyung Soon Song; Ji-Hyuk Rhee
Journal:  Yonsei Med J       Date:  2006-04-30       Impact factor: 2.759

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.